L Horn Selected Research

Neoplasms (Cancer)

10/2020	Immunometabolic Status of COVID-19 Cancer Patients.
1/2017	Pembrolizumab as first-line therapy for patients with PD-L1-positive advanced non-small cell lung cancer: a phase 1 trial.
1/2016	Systematic evaluation of pembrolizumab dosing in patients with advanced non-small-cell lung cancer.
1/2001	Pharmacological determinants of 9-aminocamptothecin cytotoxicity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

L Horn Research Topics

Disease

6	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2020 - 01/2016
4	Neoplasms (Cancer) 10/2020 - 01/2001
2	Neoplasm Metastasis (Metastasis) 01/2021 - 01/2018
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2021 - 01/2020
2	Disease Progression 01/2020 - 01/2018
2	Exanthema (Rash) 01/2020 - 01/2020
1	Virus Diseases (Viral Diseases) 10/2020
1	Infections 10/2020
1	COVID-19 10/2020
1	Hypothyroidism 01/2020
1	Diarrhea 01/2020
1	Lung Neoplasms (Lung Cancer) 01/2020
1	Nausea 01/2020
1	Vomiting 01/2020
1	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2020
1	Hemorrhage 01/2018
1	Thrombocytopenia (Thrombopenia) 12/2002
1	Tuberculosis (Tuberculoses) 09/2001
1	Poisoning 01/2001

Drug/Important Bio-Agent (IBA)

2	NivolumabIBA 01/2021 - 01/2018
2	Docetaxel (Taxotere)FDA Link 01/2018 - 01/2018
2	pembrolizumabIBA 01/2017 - 01/2016
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2021
1	NAD (NADH)IBA 10/2020
1	Angiotensin-Converting Enzyme 2IBA 10/2020
1	atezolizumabIBA 01/2020
1	osimertinibIBA 01/2020
1	durvalumabIBA 01/2020
1	AZD 6244IBA 01/2020
1	Etoposide (VP 16)FDA LinkGeneric 01/2020
1	1- (1- (imidazo(1,2- a)pyridin- 6- yl)ethyl)- 6- (1- methyl- 1H- pyrazol- 4- yl)- 1H- (1,2,3)triazolo(4,5- b)pyrazineIBA 01/2020
1	Carboplatin (JM8)FDA LinkGeneric 01/2020
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2019
1	naquotinibIBA 01/2019
1	Gefitinib (Iressa)FDA Link 01/2019
1	bavituximabIBA 01/2018
1	EnzymesIBA 01/2018
1	Immune Checkpoint InhibitorsIBA 01/2018
1	PlatinumIBA 01/2018
1	B7-H1 AntigenIBA 01/2017
1	Heparin (Liquaemin)FDA LinkGeneric 12/2002
1	Pharmaceutical PreparationsIBA 09/2001
1	CamptothecinIBA 01/2001
1	9-aminocamptothecinIBA 01/2001
1	Antineoplastic Agents (Antineoplastics)IBA 01/2001
1	Culture MediaIBA 01/2001
1	Type I DNA Topoisomerases (Topoisomerase I)IBA 01/2001
1	9-aminocamptothecin lactoneIBA 01/2001

Therapy/Procedure

4	Therapeutics 10/2020 - 09/2001
2	Drug Therapy (Chemotherapy) 01/2018 - 01/2017
1	Aftercare (After-Treatment) 01/2018
1	Cardiopulmonary Bypass (Heart-Lung Bypass) 12/2002